e-learning
resources
Amsterdam 2011
Tuesday, 27.09.2011
Cystic fibrosis: new basic, clinical and bacteriological knowledge
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Molecular structure, packing and release of MUC2 with relevance to cystic fibrosis
H. Nilsson, D. Ambort, G. Hansson, H. Hebert (Huddinge, Gothenburg, Sweden)
Source:
Annual Congress 2011 - Cystic fibrosis: new basic, clinical and bacteriological knowledge
Session:
Cystic fibrosis: new basic, clinical and bacteriological knowledge
Session type:
Poster Discussion
Number:
4551
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
H. Nilsson, D. Ambort, G. Hansson, H. Hebert (Huddinge, Gothenburg, Sweden). Molecular structure, packing and release of MUC2 with relevance to cystic fibrosis. Eur Respir J 2011; 38: Suppl. 55, 4551
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: Lung function in epidemiological studies from infancy to childhood with focus on urban environment
Cystic fibrosis and intestinal organoids
Clinics of Cystic Fibrosis Patients with Unusual Bacteria Isolated fromRespiratory Cultures
Related content which might interest you:
Atypical cystic fibrosis
Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-46-6, page=38
Year: 2006
Pharmacological treatment of the biochemical defect in cystic fibrosis airways
Source: Eur Respir J 2001; 17: 1314-1321
Year: 2001
Primary ciliary dyskinesia and mild cystic fibrosis: lung structure and function similarities.
Source: International Congress 2017 – Paediatric bronchology in clinical practice
Year: 2017
Expression of HCLCA1 in cystic fibrosis lungs is associated with mucus overproduction
Source: Eur Respir J 2004; 23: 846-850
Year: 2004
Pharmacology and regulation of ENaC function: implication in cystic fibrosis
Source: Annual Congress 2009 - Novel regulators of alveolar liquid clearance
Year: 2009
Cystic fibrosis transmembrane conductance regulator pharmacotherapy
Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-46-6, page=88
Year: 2006
Is ceramide the missing link between the molecular defect and the lung disease of cystic fibrosis?
Source: Breathe 2008; 4: 365
Year: 2008
Peptide transport mechanisms in cystic fibrosis and normal human lung
Source: Eur Respir J 2001; 18: Suppl. 33, 76s
Year: 2001
Treatment of cystic fibrosis airway cells with CFTR modulators reverses aberrant mucus properties
via
hydration
Source: Eur Respir J, 59 (2) 2100185; 10.1183/13993003.00185-2021
Year: 2022
Differential expression of tenascin C splice variants in endobronchial epithelial-lining fluid in proximity of pulmonary nodules
Source: Annual Congress 2013 –Translational research to bridge the need within clinical decision making
Year: 2013
Inflammation in cystic fibrosis airways: relationship to increased bacterial adherence
Source: Eur Respir J 2001; 17: 27-35
Year: 2001
Targeting a genetic defect: cystic fibrosis transmembrane conductance regulator modulators in cystic fibrosis
Source: Eur Respir Rev 2013; 22: 58-65
Year: 2013
MiR-145 and SMAD3 expression in patients with cystic fibrosis
Source: Annual Congress 2013 –Cystic fibrosis: basic and applied science
Year: 2013
Optimal correction of distinct CFTR folding mutants in rectal cystic fibrosis organoids
Source: Eur Respir J 2016; 48: 451-458
Year: 2016
The role of extracellular vesicles in phenotypic alteration of lung cells in pulmonary fibrosis
Source: Annual Congress 2013 –The role of hormones and cytokines in lung injury
Year: 2013
New insights into the pathophysiology of lung disease in cystic fibrosis patients
Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-46-6, page=1
Year: 2006
Molecular detection of complex microbial communities in sputa of patients with cystic fibrosis and non cystic fibrosis bronchiectasis
Source: Annual Congress 2010 - Cystic fibrosis: lung disease infection and more
Year: 2010
CFTR: cystic fibrosis and beyond
Source: Eur Respir J 2014; 44: 1042-1054
Year: 2014
Expression of the nuclear factor-?B inhibitor A20 is altered in the cystic fibrosis epithelium
Source: Eur Respir J 2013; 41: 1315-1323
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept